Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

计划入组 3,423 人 · 首次发布于 2015 年 9 月 22 日

A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis

计划入组 127 人 · 首次发布于 2011 年 11 月 11 日

DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%

计划入组 489 人 · 首次发布于 2011 年 4 月 26 日

Alcaftadine(Lastacaft)

C₁₉H₂₁N₃O · Rx

C-KAD ophthalmic solution(Chakshu)

Ophthalmic diseases(Spotlight)

Elite Pharmaceutical Solution Inc.

United States

Bio Solution Co., Ltd.

South Korea

Implandata Ophthalmic Products GmbH

Germany

Alembic Pharma Gains USFDA Approval for OTC Alcaftadine Ophthalmic Solution

FDC Limited Receives FDA Approval for Generic Pilocarpine HCl Ophthalmic Solution

Perfluorohexyloctane Shows Promise for Dry Eye Disease in Pooled Phase 3 Analysis